Fulgent Genetics (FLGT) EBIT Margin (2015 - 2026)
Fulgent Genetics' (FLGT) quarterly EBIT Margin came in at 42.25% in Q2 2026, down 1815.0% year-over-year from 2.46% in Q2 2025, and up 13.2% quarter-over-quarter from 48.67% in Q1 2026.
Powered by 
Analysis
Fulgent Genetics (FLGT) EBIT Margin (2015 - 2026) Analysis & Trends
Fulgent Genetics has disclosed EBIT Margin across 12 years of filings, most recently posting 42.25% for Q2 2026.
- In Q2 2026, EBIT Margin fell 1815.0% year-over-year to 42.25%; the TTM figure through Jun 2026 stood at 35.91% (down 1193.0% YoY), while the FY2025 annual figure was 28.23%, down 216.0% from the prior year.
- EBIT Margin came in at 42.25% for Q2 2026 at Fulgent Genetics, up from 48.67% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 63.05% in Q1 2022 to a low of 214.34% in Q4 2023.
- Average EBIT Margin over 5 years is 35.64%, with a median of 26.78% recorded in 2024.
- Year-over-year, EBIT Margin sank 17062 bps in 2023 and surged 19317 bps in 2024.
- Over 5 years, EBIT Margin stood at 43.72% in 2022, then slumped by 390 bps to 214.34% in 2023, then surged by 90 bps to 21.17% in 2024, then plunged by 490 bps to 125.0% in 2025, then surged by 66 bps to 42.25% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 42.25% in Q2 2026, 48.67% in Q1 2026, and 125.0% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -10.07% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 15.08% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 12.10% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | -38.55% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | -19.85% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 10.21% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 34.17% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 5.03% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -22.04% |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn | -42.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -42.25% |
| Mar 31, 2026 | -48.67% |
| Dec 31, 2025 | -125.00% |
| Sep 30, 2025 | -18.26% |
| Jun 30, 2025 | -24.10% |
| Mar 31, 2025 | -26.95% |
| Dec 31, 2024 | -21.17% |
| Sep 30, 2024 | -23.81% |
| Jun 30, 2024 | -26.62% |
| Mar 31, 2024 | -33.80% |
| Dec 31, 2023 | -214.34% |
| Sep 30, 2023 | 0.25% |
| Jun 30, 2023 | -29.18% |
| Mar 31, 2023 | -37.52% |
| Dec 31, 2022 | -43.72% |
| Sep 30, 2022 | 0.33% |
| Jun 30, 2022 | 10.21% |
| Mar 31, 2022 | 63.05% |
| Dec 31, 2021 | 59.94% |
| Sep 30, 2021 | 69.90% |